Recipients of heart transplant surgery due to end-stage heart failure, primarily resulting from dilated cardiomyopathy (DCM), were identified based on their medical history, cardiac ultrasound, and serum biomarkers including N-terminal pro-B-type natriuretic peptide (NT-proBNP). The gene discussed is NPPB; the disease is dilated cardiomyopathy.